Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,301,745
-
Share change
-
-48,339
-
Total reported value
-
$15,950,000
-
Price per share
-
$6.92
-
Number of holders
-
19
-
Value change
-
-$269,773
-
Number of buys
-
11
-
Number of sells
-
8
Institutional Holders of IMPRIMIS PHARMACEUTICALS INC - COM NEW (IMMY) as of Q4 2015
As of 31 Dec 2015,
IMPRIMIS PHARMACEUTICALS INC - COM NEW (IMMY) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,301,745 shares.
The largest 10 holders included
Opaleye Management Inc., INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, Granite Investment Partners, LLC, NORTHERN TRUST CORP, REGIONS FINANCIAL CORP, Atlantic Trust Group, LLC, MARATHON CAPITAL MANAGEMENT, BlackRock Fund Advisors, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.